No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Antiphospholipid Syndrome / blood
-
Antiphospholipid Syndrome / complications
-
Antiphospholipid Syndrome / diagnosis*
-
Antiphospholipid Syndrome / drug therapy
-
Antiphospholipid Syndrome / immunology
-
Biomarkers / blood
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Immunologic Tests / standards*
-
Lupus Coagulation Inhibitor / blood*
-
Odds Ratio
-
Patient Selection
-
Practice Guidelines as Topic
-
Predictive Value of Tests
-
Prognosis
-
Risk Factors
-
Thromboembolism / blood
-
Thromboembolism / etiology
-
Thromboembolism / immunology
-
Thromboembolism / prevention & control
Substances
-
Anticoagulants
-
Biomarkers
-
Fibrinolytic Agents
-
Lupus Coagulation Inhibitor